Prion strain interactions are highly selective

Journal of Neuroscience

Volumn 30, Issue 36, 2010, Pages 12094-12102

  Nilsson, K Peter R ^a   Joshi Barr, Shivanjali ^b,c   Winson, Olivia ^b,c   Sigurdson, Christina J ^b,c,d  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; AMYLOID; CELL PROTEIN; POLYTHIOPHENE ACETIC ACID; PRION PROTEIN; UNCLASSIFIED DRUG; GLIAL FIBRILLARY ACIDIC PROTEIN; POLYMER; POLYTHIOPHENE; PRION; SACCHAROMYCES CEREVISIAE PROTEIN; THIOPHENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; HISTOPATHOLOGY; HYBRID; IN VIVO STUDY; MALE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PARIETAL LOBE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN INTERACTION; SPECTROSCOPY; WESTERN BLOTTING; ANIMAL; BOVINAE; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN; CHEMISTRY; CLASSIFICATION; DIAGNOSTIC USE; DISEASE MODEL; METABOLISM; MORTALITY; PATHOLOGY; PRION; PRION DISEASE; PROCEDURES; PROTEIN QUATERNARY STRUCTURE; SCRAPIE; SEVERITY OF ILLNESS INDEX; SHEEP; SPECIES DIFFERENCE; STATISTICS; STRUCTURE ACTIVITY RELATION; SURVIVAL; TRANSGENIC MOUSE; TRANSMISSION; VETERINARY;

AMYLOID; ANIMALS; BRAIN; CATTLE; DISEASE MODELS, ANIMAL; ENCEPHALOPATHY, BOVINE SPONGIFORM; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; MICE; MICE, TRANSGENIC; POLYMERS; PRION DISEASES; PRIONS; PROTEIN STRUCTURE, QUATERNARY; SACCHAROMYCES CEREVISIAE PROTEINS; SCRAPIE; SEVERITY OF ILLNESS INDEX; SHEEP; SPECIES SPECIFICITY; SPECTRUM ANALYSIS; STATISTICS AS TOPIC; STRUCTURE-ACTIVITY RELATIONSHIP; SURVIVAL ANALYSIS; THIOPHENES;

EID: 77956591493     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2417-10.2010     Document Type: Article

References (49)

1. Andersson MR, Berggren M, Olinga T, Hjertberg T, Inganas O, Wennerstrom O (1997) Improved photoluminescence efficiency of films from conjugated polymers. Synth Met 85:1383-1384. (Pubitemid 127366288)
2. Bartz JC, Aiken JM, Bessen RA (2004) Delay in onset of prion disease for the HY strain of transmissible mink encephalopathy as a result of prior peripheral inoculation with the replication-deficient DY strain. J Gen Virol 85:265-273.
3. Bartz JC, Kramer ML, Sheehan MH, Hutter JA, Ayers JI, Bessen RA, Kincaid AE (2007) Prion interference is due to a reduction in strain-specific PrPSc levels. J Virol 81:689-697.
4. Berggren M, Bergman P, Fagerstrom J, Inganas O, Andersson M, Weman H, Granstrom M, Stafstrom S, Wennerstrom O, Hjertberg T (1999) Controlling inter-chain and intra-chain excitations of a poly(thiophene) derivative in thin films. Chem Phys Lett 304:84-90. (Pubitemid 129610058)
5. Bessen RA, Marsh RF (1992) Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 66:2096-2101.
6. Bruce ME, McBride PA, Farquhar CF (1989) Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie. Neurosci Lett 102:1-6.
7. Bruce ME, McConnell I, Fraser H, Dickinson AG (1991) The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 72:595-603.
8. Calamai M, Kumita JR, Mifsud J, Parrini C, Ramazzotti M, Ramponi G, Taddei N, Chiti F, Dobson CM (2006) Nature and significance of the interactions between amyloid fibrils and biological polyelectrolytes. Biochemistry 45:12806-12815. (Pubitemid 44630867)
9. Cali I, Castellani R, Alshekhlee A, Cohen Y, Blevins J, Yuan J, Langeveld JP, Parchi P, Safar JG, Zou WQ, Gambetti P (2009) Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 132:2643-2658.
10. Collins SR, Douglass A, Vale RD, Weissman JS (2004) Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol 2:e321.
11. Come JH, Fraser PE, Lansbury PT Jr (1993) A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci U S A 90:5959-5963.
12. Debatin L, Streffer J, Geissen M, Matschke J, Aguzzi A, Glatzel M (2008) Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease. Neurodegener Dis 5:347-354.
13. Deleault NR, Lucassen RW, Supattapone S (2003) RNA molecules stimulate prion protein conversion. Nature 425:717-720.
14. Deleault NR, Geoghegan JC, Nishina K, Kascsak R, Williamson RA, Supattapone S (2005) Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J Biol Chem 280:26873-26879.
15. Dickinson AG, Fraser H, Meikle VM, Outram GW (1972) Competition between different scrapie agents in mice. Nat New Biol 237:244-245.
16. Dickinson AG, Fraser H, McConnell I, Outram GW, Sales DI, Taylor DM (1975) Extraneural competition between different scrapie agents leading to loss of infectivity. Nature 253:556.
17. Ding L, Jonforsen M, Roman LS, Andersson MR, Inganas O (2000) Photovoltaic cells with a conjugated polyelectrolyte. Synth Met 110:133-140.
18. Duda JE, Giasson BI, Mabon ME, Miller DC, Golbe LI, Lee VM, Trojanowski JQ (2002) Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol 104:7-11.
19. Fischer M, Rülicke T, Raeber A, Sailer A, Moser M, Oesch B, Brandner S, Aguzzi A, Weissmann C (1996) Prion protein (PrP) with aminoproximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 15:1255-1264. (Pubitemid 26093461)
20. Fraser H, Dickinson AG (1968) The sequential development of the brain lesion of scrapie in three strains of mice. J Comp Pathol 78:301-311.
21. Fraser H, Dickinson AG (1973) Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J Comp Pathol 83:29-40.
22. Ghoshal N, Cali I, Perrin RJ, Josephson SA, Sun N, Gambetti P, Morris JC (2009) Codistribution of amyloid beta plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype. Arch Neurol 66:1240-1246.
23. Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, Trojanowski JQ, Lee VM (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300:636-640.
24. Ho HA, Boissinot M, Bergeron MG, Corbeil G, Doré K, Boudreau D, Leclerc M (2002) Colorimetric and fluorometric detection of nucleic acids using cationic polythiophene derivatives. Angew Chem Int Ed Engl 41:1548-1551.
25. Lundmark K, Westermark GT, Olsén A, Westermark P (2005) Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: cross-seeding as a disease mechanism. Proc Natl Acad Sci U S A 102:6098-6102.
26. Manuelidis L (1998) Vaccination with an attenuated Creutzfeldt-Jakob disease strain prevents expression of a virulent agent. Proc Natl Acad Sci U S A 95:2520-2525.
27. Manuelidis L, Lu ZY (2003) Virus-like interference in the latency and prevention of Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A 100:5360-5365. (Pubitemid 36542710)
28. Marui W, Iseki E, Uéda K, Kosaka K (2000) Occurrence of human alpha-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer's disease. J Neurol Sci 174:81-84.
29. Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L (2001) β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci U S A 98:12245-12250.
30. Morales R, Estrada LD, Diaz-Espinoza R, Morales-Scheihing D, Jara MC, Castilla J, Soto C (2010) Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases. J Neurosci 30:4528-4535.
31. Muramoto T, Kitamoto T, Koga H, Tateishi J (1992) The coexistence of Alzheimer's disease and Creutzfeldt-Jakob disease in a patient with dementia of long duration. Acta Neuropathol Berl 84:686-689.
32. Nilsson KP, Andersson MR, Inganas O (2002) Conformational transitions of a free amino-acid-functionalized polythiophene induced by different buffer systems. J Phys Condens Matter 14:10011-10020.
33. Nilsson KP, Rydberg J, Baltzer L, Inganäs O (2003) Self-assembly of synthetic peptides control conformation and optical properties of a zwitterionic polythiophene derivative. Proc Natl Acad Sci U S A 100:10170-10174. (Pubitemid 37071851)
34. Nilsson KP, Rydberg J, Baltzer L, Inganäs O (2004) Twisting macromolecular chains: self-assembly of a chiral supermolecule from nonchiral polythiophene polyanions and random-coil synthetic peptides. Proc Natl Acad Sci U S A 101:11197-11202.
35. Nilsson KP, Aslund A, Berg I, Nyström S, Konradsson P, Herland A, Inganäs O, Stabo-Eeg F, Lindgren M, Westermark GT, Lannfelt L, Nilsson LN, Hammarström P (2007) Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes. ACS Chem Biol 2:553-560.
36. Nilsson KP, Ikenberg K, Aslund A, Fransson S, Konradsson P, Röcken C, Moch H, Aguzzi A (2010) Structural typing of systemic amyloidoses by luminescent-conjugated polymer spectroscopy. Am J Pathol 176:563-574.
37. Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, Burton DR, DeArmond SJ, Prusiner SB, Scott MR (2002) A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 34:921-932. (Pubitemid 34722282)
38. Polymenidou M, Stoeck K, Glatzel M, Vey M, Bellon A, Aguzzi A (2005) Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol 4:805-814.
39. Polymenidou M, Moos R, Scott M, Sigurdson C, Shi YZ, Yajima B, Hafner-Bratkovic I, Jerala R, Hornemann S, Wuthrich K, Bellon A, Vey M, Garen G, James MN, Kav N, Aguzzi A (2008) The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes. PLoS ONE 3:e3872.
40. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136-144.
41. Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, Tagliavini F (1999) Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP(Sc) in the same brain. Neurology 53:2173-2176.
42. Sc molecules with different conformations. Nat Med 4:1157-1165.
43. Schmidt ML, Martin JA, Lee VM, Trojanowski JQ (1996) Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders. Acta Neuropathol 91:475-481. (Pubitemid 126523819)
44. Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ (2009) A clinico-pathological study of subtypes in Parkinson's disease. Brain 132:2947-2957.
45. Sigurdson CJ, Manco G, Schwarz P, Liberski P, Hoover EA, Hornemann S, Polymenidou M, Miller MW, Glatzel M, Aguzzi A (2006) Strain fidelity of chronic wasting disease upon murine adaptation. J Virol 80:12303-12311.
46. Sigurdson CJ, Nilsson KP, Hornemann S, Manco G, Polymenidou M, Schwarz P, Leclerc M, Hammarström P, Wüthrich K, Aguzzi A (2007) Prion strain discrimination using luminescent conjugated polymers. Nat Methods 4:1023-1030.
47. Small SA, Duff K (2008) Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron 60:534-542.
48. Tsigelny IF, Crews L, Desplats P, Shaked GM, Sharikov Y, Mizuno H, Spencer B, Rockenstein E, Trejo M, Platoshyn O, Yuan JX, Masliah E (2008) Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases. PLoS One 3:e3135.
49. Uro-Coste E, Cassard H, Simon S, Lugan S, Bilheude JM, Perret-Liaudet A, Ironside JW, Haik S, Basset-Leobon C, Lacroux C, Peoch K, Streichenberger N, Langeveld J, Head MW, Grassi J, Hauw JJ, Schelcher F, Delisle MB, Andreoletti O (2008) Beyond PrP res type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog 4:e1000029.